[
  {
    "ts": "2026-02-09T09:13:34+00:00",
    "headline": "Novo Nordisk shares rise as Hims abandons $49 weight-loss pill",
    "summary": "COPENHAGEN, Feb 9 () - Novo Nordisk's shares jumped more than 8% on Monday after telehealth firm Hims & Hers cancelled the launch of ​a $49 weight-loss pill over the weekend, following legal threats from ‌Novo and the U. Hims introduced the compounded pill based on semaglutide - ‌a key ingredient in Novo's blockbuster drugs Wegovy and Ozempic - last Thursday, prompting pushback from the Danish drugmaker and regulatory authorities.",
    "url": "https://uk.finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "eba1a6c5-1069-3b02-9249-bb65961b531a",
      "content": {
        "id": "eba1a6c5-1069-3b02-9249-bb65961b531a",
        "contentType": "STORY",
        "title": "Novo Nordisk shares rise as Hims abandons $49 weight-loss pill",
        "description": "",
        "summary": "COPENHAGEN, Feb 9 () - Novo Nordisk's shares jumped more than 8% on Monday after telehealth firm Hims & Hers cancelled the launch of ​a $49 weight-loss pill over the weekend, following legal threats from ‌Novo and the U. Hims introduced the compounded pill based on semaglutide - ‌a key ingredient in Novo's blockbuster drugs Wegovy and Ozempic - last Thursday, prompting pushback from the Danish drugmaker and regulatory authorities.",
        "pubDate": "2026-02-09T09:13:34Z",
        "displayTime": "2026-02-09T09:13:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/169cee0bf3615c357bb727c349a37c1f",
          "originalWidth": 800,
          "originalHeight": 527,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q5tu47T4jLBH.vaRgG7MVg--~B/aD01Mjc7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/169cee0bf3615c357bb727c349a37c1f.cf.webp",
              "width": 800,
              "height": 527,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jfLTpFgNiIdojq6eRefROQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/169cee0bf3615c357bb727c349a37c1f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://uk.finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
          "site": "finance",
          "region": "GB",
          "lang": "en-GB"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T05:57:00+00:00",
    "headline": "Innovent Biologics Strikes Partnership Deal With Eli Lilly",
    "summary": "Chinese drugmaker Innovent Biologics and Eli Lilly plan to target cancer and immune system diseases under the partnership.",
    "url": "https://www.wsj.com/tech/biotech/innovent-biologics-strikes-partnership-deal-with-eli-lilly-fa6713f9?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "ac224973-802c-35d2-b975-9398f85a9adb",
      "content": {
        "id": "ac224973-802c-35d2-b975-9398f85a9adb",
        "contentType": "STORY",
        "title": "Innovent Biologics Strikes Partnership Deal With Eli Lilly",
        "description": "",
        "summary": "Chinese drugmaker Innovent Biologics and Eli Lilly plan to target cancer and immune system diseases under the partnership.",
        "pubDate": "2026-02-09T05:57:00Z",
        "displayTime": "2026-02-09T05:57:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/ac224973-802c-35d2-b975-9398f85a9adb/innovent-biologics-strikes.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/6914d8a6fb87a081fde515b59bae8642",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LXMe.ymKL_eN79CDkj2a9w--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/6914d8a6fb87a081fde515b59bae8642.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ciE_MH1eMDoSTjrzHtPh1w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/6914d8a6fb87a081fde515b59bae8642.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/tech/biotech/innovent-biologics-strikes-partnership-deal-with-eli-lilly-fa6713f9?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IVBIY"
            },
            {
              "symbol": "IVBXF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T11:36:51+00:00",
    "headline": "Hims & Hers Halts Knockoff Wegovy Pill After Just Two Days: Here's Why",
    "summary": "Hims & Hers backed down under FDA pressure two days just after launching the copycat version of Novo Nordisk's weight-loss pill.",
    "url": "https://www.investors.com/news/technology/hims-hers-health-stops-offering-knockoff-wegovy-pill-fda-crackdown/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "1002bb24-5eb4-303a-9144-64abe04a7a40",
      "content": {
        "id": "1002bb24-5eb4-303a-9144-64abe04a7a40",
        "contentType": "STORY",
        "title": "Hims & Hers Halts Knockoff Wegovy Pill After Just Two Days: Here's Why",
        "description": "",
        "summary": "Hims & Hers backed down under FDA pressure two days just after launching the copycat version of Novo Nordisk's weight-loss pill.",
        "pubDate": "2026-02-09T11:36:51Z",
        "displayTime": "2026-02-09T11:36:51Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/1002bb24-5eb4-303a-9144-64abe04a7a40/hims-hers-halts-knockoff.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/6cfe027a47fbde4d7312dced314aff0b",
          "originalWidth": 1000,
          "originalHeight": 511,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3O3uCGa3Xeq_MEs22jdHiA--~B/aD01MTE7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/6cfe027a47fbde4d7312dced314aff0b.cf.webp",
              "width": 1000,
              "height": 511,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pXxP9EU.MV8rjo4qP_AZ6Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/6cfe027a47fbde4d7312dced314aff0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/hims-hers-health-stops-offering-knockoff-wegovy-pill-fda-crackdown/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "VKTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T11:01:26+00:00",
    "headline": "Innovent and Lilly to advance new oncology and immunology medicines",
    "summary": "Innovent will receive an upfront payment of $350m under the agreement.",
    "url": "https://www.pharmaceutical-technology.com/news/innovent-lilly-oncology-immunology-medicines/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "51b5b7c4-3612-3e75-baf4-634022fe74da",
      "content": {
        "id": "51b5b7c4-3612-3e75-baf4-634022fe74da",
        "contentType": "STORY",
        "title": "Innovent and Lilly to advance new oncology and immunology medicines",
        "description": "",
        "summary": "Innovent will receive an upfront payment of $350m under the agreement.",
        "pubDate": "2026-02-09T11:01:26Z",
        "displayTime": "2026-02-09T11:01:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/e614c70ad9a5dd9b5dcfdbfe505debec",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "Lilly will hold exclusive rights to develop and commercialise the programmes outside Greater China. Credit: Tada Images / Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FX.zvlGi.f9_JeOu6nEe8A--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/e614c70ad9a5dd9b5dcfdbfe505debec.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KXKsQ7DfZB7py4t8rztnOQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/e614c70ad9a5dd9b5dcfdbfe505debec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/innovent-lilly-oncology-immunology-medicines/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/innovent-lilly-advance-oncology-immunology-110126837.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IVBIY"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T10:49:22+00:00",
    "headline": "Novo Nordisk surges as Hims pulls $49 weight loss pill under FDA pressure",
    "summary": "COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk's shares jumped more than 8% on Monday after telehealth firm Hims & Hers cancelled the launch of a $49 copy of a weight-loss pill following legal threats from the ​Danish group and the U. The gains pushed Novo's shares higher than before Hims announced ‌its non-FDA-approved version of Novo's semaglutide as investors perceived the FDA actions as a broader crackdown on compounded GLP-1 drugs, which could reduce competitive threats ‌to branded treatments,",
    "url": "https://uk.finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "eba1a6c5-1069-3b02-9249-bb65961b531a",
      "content": {
        "id": "eba1a6c5-1069-3b02-9249-bb65961b531a",
        "contentType": "STORY",
        "title": "Novo Nordisk surges as Hims pulls $49 weight loss pill under FDA pressure",
        "description": "",
        "summary": "COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk's shares jumped more than 8% on Monday after telehealth firm Hims & Hers cancelled the launch of a $49 copy of a weight-loss pill following legal threats from the ​Danish group and the U. The gains pushed Novo's shares higher than before Hims announced ‌its non-FDA-approved version of Novo's semaglutide as investors perceived the FDA actions as a broader crackdown on compounded GLP-1 drugs, which could reduce competitive threats ‌to branded treatments,",
        "pubDate": "2026-02-09T10:49:22Z",
        "displayTime": "2026-02-09T10:49:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-02/9cb75f20-05a2-11f1-bf97-4d2d6778d96c",
          "originalWidth": 4448,
          "originalHeight": 2911,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/su9pm8YI6lLwNbzBqOF_Ow--~B/aD0yOTExO3c9NDQ0ODthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-02/9cb75f20-05a2-11f1-bf97-4d2d6778d96c.cf.webp",
              "width": 4448,
              "height": 2911,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pThKw72ZHlLccJT5LV59Vg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-02/9cb75f20-05a2-11f1-bf97-4d2d6778d96c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://uk.finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
          "site": "finance",
          "region": "GB",
          "lang": "en-GB"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T13:07:45+00:00",
    "headline": "Novo Nordisk sues Hims over scrapped $49 weight-loss pill copy",
    "summary": "COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk sued Hims and Hers Health on Monday over patent infringement after the U. telehealth firm launched, then cancelled, a $49 copy of Novo's weight-loss pill Wegovy following backlash from the U.",
    "url": "https://uk.finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "eba1a6c5-1069-3b02-9249-bb65961b531a",
      "content": {
        "id": "eba1a6c5-1069-3b02-9249-bb65961b531a",
        "contentType": "STORY",
        "title": "Novo Nordisk sues Hims over scrapped $49 weight-loss pill copy",
        "description": "",
        "summary": "COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk sued Hims and Hers Health on Monday over patent infringement after the U. telehealth firm launched, then cancelled, a $49 copy of Novo's weight-loss pill Wegovy following backlash from the U.",
        "pubDate": "2026-02-09T13:07:45Z",
        "displayTime": "2026-02-09T13:07:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/6442b2cd483ff58c06265f8cc7742d06",
          "originalWidth": 800,
          "originalHeight": 527,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PZBBnZmdOYlNatk_bCEitg--~B/aD01Mjc7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/6442b2cd483ff58c06265f8cc7742d06.cf.webp",
              "width": 800,
              "height": 527,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s_iv1jzQesLYqedbwA6AAA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/6442b2cd483ff58c06265f8cc7742d06.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://uk.finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
          "site": "finance",
          "region": "GB",
          "lang": "en-GB"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T12:29:49+00:00",
    "headline": "Eli Lilly Pays $350 Million Upfront in China Biotech Collaboration Deal",
    "summary": "Lilly partners with Innovent on new cancer and immune therapies, with potential milestones reaching $8.5 billion.",
    "url": "https://finance.yahoo.com/news/eli-lilly-pays-350-million-122949729.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "8cac6ed9-5341-3411-8043-e61f21c2d0b9",
      "content": {
        "id": "8cac6ed9-5341-3411-8043-e61f21c2d0b9",
        "contentType": "STORY",
        "title": "Eli Lilly Pays $350 Million Upfront in China Biotech Collaboration Deal",
        "description": "",
        "summary": "Lilly partners with Innovent on new cancer and immune therapies, with potential milestones reaching $8.5 billion.",
        "pubDate": "2026-02-09T12:29:49Z",
        "displayTime": "2026-02-09T12:29:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-pays-350-million-122949729.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-pays-350-million-122949729.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "IVBIY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T12:09:42+00:00",
    "headline": "Lilly to buy Orna Therapeutics for up to $2.4 billion",
    "summary": "Feb 9 () - ​Eli ‌Lilly will ‌acquire therapy developer ⁠Orna ‌Therapeutics for ‍up to $2.4 ​billion ‌in cash, the companies said ⁠on ​Monday.",
    "url": "https://finance.yahoo.com/news/lilly-buy-orna-therapeutics-2-120647594.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "5fa5d140-6f69-3d1f-b2ce-4ad976e28c3c",
      "content": {
        "id": "5fa5d140-6f69-3d1f-b2ce-4ad976e28c3c",
        "contentType": "STORY",
        "title": "Lilly to buy Orna Therapeutics for up to $2.4 billion",
        "description": "",
        "summary": "Feb 9 () - ​Eli ‌Lilly will ‌acquire therapy developer ⁠Orna ‌Therapeutics for ‍up to $2.4 ​billion ‌in cash, the companies said ⁠on ​Monday.",
        "pubDate": "2026-02-09T12:09:42Z",
        "displayTime": "2026-02-09T12:09:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/88067dcdf26eb7cd865b0351e7cf4761",
          "originalWidth": 800,
          "originalHeight": 534,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/W4xEEapkjl_F8UjQkAXuEQ--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/88067dcdf26eb7cd865b0351e7cf4761.cf.webp",
              "width": 800,
              "height": 534,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cRAN5AhV92dlokNCx_tIdA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/88067dcdf26eb7cd865b0351e7cf4761.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lilly-buy-orna-therapeutics-2-120647594.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-buy-orna-therapeutics-2-120647594.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T12:00:00+00:00",
    "headline": "Lilly to acquire Orna Therapeutics to advance cell therapies",
    "summary": "Eli Lilly and Company (NYSE: LLY) and Orna Therapeutics, Inc., a biotechnology company dedicated to engineering immune cells in vivo, today announced entry into a definitive agreement for Lilly to acquire Orna.",
    "url": "https://finance.yahoo.com/news/lilly-acquire-orna-therapeutics-advance-120000426.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "dcfd5072-9ddc-32d4-af3b-f8f883e5a79f",
      "content": {
        "id": "dcfd5072-9ddc-32d4-af3b-f8f883e5a79f",
        "contentType": "STORY",
        "title": "Lilly to acquire Orna Therapeutics to advance cell therapies",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE: LLY) and Orna Therapeutics, Inc., a biotechnology company dedicated to engineering immune cells in vivo, today announced entry into a definitive agreement for Lilly to acquire Orna.",
        "pubDate": "2026-02-09T12:00:00Z",
        "displayTime": "2026-02-09T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/df345efe9aaf8625c1224e8763d43e53",
          "originalWidth": 400,
          "originalHeight": 124,
          "caption": "(PRNewsfoto/Eli Lilly and Company)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dqh2.OUhDnbMQOuq0T.AIQ--~B/aD0xMjQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/df345efe9aaf8625c1224e8763d43e53.cf.webp",
              "width": 400,
              "height": 124,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wwDB4ilF3A4GGRE1cktfIw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/df345efe9aaf8625c1224e8763d43e53.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lilly-acquire-orna-therapeutics-advance-120000426.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-acquire-orna-therapeutics-advance-120000426.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T11:46:52+00:00",
    "headline": "Novo Nordisk Stock Soars After Hims & Hers Scraps Copycat Weight-Loss Pill",
    "summary": "Novo Nordisk stock surged after Hims & Hers scrapped plans to sell a copycat version of the drugmaker’s weight-loss pill following pressure from U.S. regulators.  Shares in Novo Nordisk jumped more than 7% in Denmark.  The stock also trades in the U.S. as an American depositary receipt with the ticker NVO.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-09-2026/card/novo-nordisk-stock-jumps-after-hims-hers-scraps-copycat-weight-loss-pill-CXu10oIH4vMHTcJywENv?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "cabf0cf8-9df4-351b-9a4c-759ff5bfe04d",
      "content": {
        "id": "cabf0cf8-9df4-351b-9a4c-759ff5bfe04d",
        "contentType": "STORY",
        "title": "Novo Nordisk Stock Soars After Hims & Hers Scraps Copycat Weight-Loss Pill",
        "description": "",
        "summary": "Novo Nordisk stock surged after Hims & Hers scrapped plans to sell a copycat version of the drugmaker’s weight-loss pill following pressure from U.S. regulators.  Shares in Novo Nordisk jumped more than 7% in Denmark.  The stock also trades in the U.S. as an American depositary receipt with the ticker NVO.",
        "pubDate": "2026-02-09T11:46:52Z",
        "displayTime": "2026-02-09T11:46:52Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/cabf0cf8-9df4-351b-9a4c-759ff5bfe04d/novo-nordisk-stock-soars.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-09-2026/card/novo-nordisk-stock-jumps-after-hims-hers-scraps-copycat-weight-loss-pill-CXu10oIH4vMHTcJywENv?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "NOVO.B"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T11:42:57+00:00",
    "headline": "Lilly Deepens Longtime Innovent Partnership",
    "summary": "Cancer and immunology programs take focus",
    "url": "https://finance.yahoo.com/news/lilly-deepens-longtime-innovent-partnership-114257054.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "fe93da76-c0b5-3aae-b208-1714b4e6f3d5",
      "content": {
        "id": "fe93da76-c0b5-3aae-b208-1714b4e6f3d5",
        "contentType": "STORY",
        "title": "Lilly Deepens Longtime Innovent Partnership",
        "description": "",
        "summary": "Cancer and immunology programs take focus",
        "pubDate": "2026-02-09T11:42:57Z",
        "displayTime": "2026-02-09T11:42:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lilly-deepens-longtime-innovent-partnership-114257054.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-deepens-longtime-innovent-partnership-114257054.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "IVBIY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T14:28:40+00:00",
    "headline": "Eli Lilly buys Orna, Novo Nordisk sues Hims & Hers, Kyndryl plunges",
    "summary": "There are a number of stocks moving on the morning of Monday, Feb. 9, including Eli Lilly (LLY), Novo Nordisk (NVO), Hims & Hers (HIMS), and Kyndryl (KD). Morning Brief Anchor Julie Hyman breaks down some of the day's trending tickers. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
    "url": "https://finance.yahoo.com/video/eli-lilly-buys-orna-novo-142840652.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "610f691e-c497-398d-bfa8-f4adca240264",
      "content": {
        "id": "610f691e-c497-398d-bfa8-f4adca240264",
        "contentType": "VIDEO",
        "title": "Eli Lilly buys Orna, Novo Nordisk sues Hims & Hers, Kyndryl plunges",
        "description": "<p>There are a number of stocks moving on the morning of Monday, Feb. 9, including Eli Lilly (<a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/quote/LLY\">LLY</a>), Novo Nordisk (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/NVO\">NVO</a>), Hims & Hers (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/HIMS\">HIMS</a>), and Kyndryl (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/KD\">KD</a>). Morning Brief Anchor <a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/author/julie-hyman/\">Julie Hyman</a> breaks down some of the day's trending tickers.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/videos/series/morning-brief/\">Morning Brief</a>.</p>",
        "summary": "There are a number of stocks moving on the morning of Monday, Feb. 9, including Eli Lilly (LLY), Novo Nordisk (NVO), Hims & Hers (HIMS), and Kyndryl (KD). Morning Brief Anchor Julie Hyman breaks down some of the day's trending tickers. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
        "pubDate": "2026-02-09T14:28:40Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-02/44f7fb20-05c3-11f1-b86d-67ba51eef664",
          "originalWidth": 5000,
          "originalHeight": 2815,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BSLhtNcD80uXBMzLMRFexg--~B/aD0yODE1O3c9NTAwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-02/44f7fb20-05c3-11f1-b86d-67ba51eef664.cf.webp",
              "width": 5000,
              "height": 2815,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QlZ1tY8X2eaHqcZShSTQFw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-02/44f7fb20-05c3-11f1-b86d-67ba51eef664.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/eli-lilly-buys-orna-novo-142840652.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/eli-lilly-buys-orna-novo-142840652.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "KD"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T13:40:35+00:00",
    "headline": "Novo Nordisk sues Hims after short-lived $49 weight-loss pill drama",
    "summary": "COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk sued Hims and Hers Health on Monday over patent infringement after the U. telehealth firm launched, then cancelled, a $49 copy of Novo's weight-loss pill Wegovy following backlash from the U.",
    "url": "https://uk.finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "eba1a6c5-1069-3b02-9249-bb65961b531a",
      "content": {
        "id": "eba1a6c5-1069-3b02-9249-bb65961b531a",
        "contentType": "STORY",
        "title": "Novo Nordisk sues Hims after short-lived $49 weight-loss pill drama",
        "description": "",
        "summary": "COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk sued Hims and Hers Health on Monday over patent infringement after the U. telehealth firm launched, then cancelled, a $49 copy of Novo's weight-loss pill Wegovy following backlash from the U.",
        "pubDate": "2026-02-09T13:40:35Z",
        "displayTime": "2026-02-09T13:40:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/6442b2cd483ff58c06265f8cc7742d06",
          "originalWidth": 800,
          "originalHeight": 527,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PZBBnZmdOYlNatk_bCEitg--~B/aD01Mjc7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/6442b2cd483ff58c06265f8cc7742d06.cf.webp",
              "width": 800,
              "height": 527,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s_iv1jzQesLYqedbwA6AAA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/6442b2cd483ff58c06265f8cc7742d06.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://uk.finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
          "site": "finance",
          "region": "GB",
          "lang": "en-GB"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T13:37:00+00:00",
    "headline": "Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion",
    "summary": "Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash.",
    "url": "https://www.wsj.com/tech/biotech/eli-lilly-to-buy-biotech-orna-therapeutics-for-up-to-2-4-billion-46afe0c6?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "58f115fa-7035-3866-a0ab-a07b98213c57",
      "content": {
        "id": "58f115fa-7035-3866-a0ab-a07b98213c57",
        "contentType": "STORY",
        "title": "Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion",
        "description": "",
        "summary": "Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash.",
        "pubDate": "2026-02-09T13:37:00Z",
        "displayTime": "2026-02-09T13:37:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/58f115fa-7035-3866-a0ab-a07b98213c57/eli-lilly-to-buy-biotech-orna.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7639a479b4889ccdcfd06dfdc20c2470",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3ENIEx0pWOH.W4O48ezfAg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7639a479b4889ccdcfd06dfdc20c2470.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/voNRAHQNLLEeD1JApd7V1Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7639a479b4889ccdcfd06dfdc20c2470.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/tech/biotech/eli-lilly-to-buy-biotech-orna-therapeutics-for-up-to-2-4-billion-46afe0c6?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T13:12:00+00:00",
    "headline": "Hims & Hers Stock Plunges. Its Weight Loss Drug Strategy Backfired.",
    "summary": "Heightened regulatory scrutiny could be a major blow for the online drug retailer, which just shelved its plan for a Wegovy copycat.",
    "url": "https://www.barrons.com/articles/hims-hers-stock-price-wight-loss-drug-novo-nordisk-llilly-wegovy-9b7e26db?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "3bdf7c21-9b76-30b5-9407-e5570705df84",
      "content": {
        "id": "3bdf7c21-9b76-30b5-9407-e5570705df84",
        "contentType": "STORY",
        "title": "Hims & Hers Stock Plunges. Its Weight Loss Drug Strategy Backfired.",
        "description": "",
        "summary": "Heightened regulatory scrutiny could be a major blow for the online drug retailer, which just shelved its plan for a Wegovy copycat.",
        "pubDate": "2026-02-09T13:12:00Z",
        "displayTime": "2026-02-09T13:12:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/3bdf7c21-9b76-30b5-9407-e5570705df84/hims-hers-stock-plunges-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/3985777ea4a8bee88d7fbde151eccb25",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/26KOn6oaSzam4fyehZ4clw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/3985777ea4a8bee88d7fbde151eccb25.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/phkijlebsiYXfKV4N8Qtzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/3985777ea4a8bee88d7fbde151eccb25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/hims-hers-stock-price-wight-loss-drug-novo-nordisk-llilly-wegovy-9b7e26db?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T12:34:00+00:00",
    "headline": "Eli Lilly Stock Rises. It’s Acquiring This Cell Therapy Company for $2.4 Billion.",
    "summary": "Eli Lilly  shares rose after the Mounjaro maker said it had agreed to acquire biotechnology company Orna Therapeutics for $2.4 billion in cash.  The deal value comprises an upfront payment and subsequent payments upon the achievement of clinical development milestones, Lilly said.  Orna Therapeutics develops RNA drugs targeting cancers, genetic disorders, and other chronic conditions.",
    "url": "https://www.barrons.com/articles/eli-lilly-stock-orna-acquisition-f7249955?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "de7539fd-667e-396a-9d25-63c19eb882e5",
      "content": {
        "id": "de7539fd-667e-396a-9d25-63c19eb882e5",
        "contentType": "STORY",
        "title": "Eli Lilly Stock Rises. It’s Acquiring This Cell Therapy Company for $2.4 Billion.",
        "description": "",
        "summary": "Eli Lilly  shares rose after the Mounjaro maker said it had agreed to acquire biotechnology company Orna Therapeutics for $2.4 billion in cash.  The deal value comprises an upfront payment and subsequent payments upon the achievement of clinical development milestones, Lilly said.  Orna Therapeutics develops RNA drugs targeting cancers, genetic disorders, and other chronic conditions.",
        "pubDate": "2026-02-09T12:34:00Z",
        "displayTime": "2026-02-09T12:34:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/de7539fd-667e-396a-9d25-63c19eb882e5/eli-lilly-stock-rises-it%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/441bbf15e12a2f0ee553d116e82ffd12",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3oke2VoyBuVXihS7iPanPA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/441bbf15e12a2f0ee553d116e82ffd12.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jF0dFF4yYnylMoHzf4gbhA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/441bbf15e12a2f0ee553d116e82ffd12.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/eli-lilly-stock-orna-acquisition-f7249955?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T15:49:07+00:00",
    "headline": "Hims & Hers stock crashes after FDA announces plans to take 'decisive steps' against GLP-1 compounds",
    "summary": "Hims & Hers stock fell sharply on Monday after the FDA said it would take steps to restrict the sale of its compounded versions of popular weight-loss drugs.",
    "url": "https://finance.yahoo.com/news/hims--hers-stock-crashes-after-fda-announces-plans-to-take-decisive-steps-against-glp-1-compounds-154907212.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "4cd53e1c-a813-4221-b601-ba25feaad118",
      "content": {
        "id": "4cd53e1c-a813-4221-b601-ba25feaad118",
        "contentType": "STORY",
        "title": "Hims & Hers stock crashes after FDA announces plans to take 'decisive steps' against GLP-1 compounds",
        "description": "",
        "summary": "Hims & Hers stock fell sharply on Monday after the FDA said it would take steps to restrict the sale of its compounded versions of popular weight-loss drugs.",
        "pubDate": "2026-02-09T15:49:07Z",
        "displayTime": "2026-02-09T15:49:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-02/ca865c10-03ab-11f1-b9f7-54bd7d25ed54",
          "originalWidth": 5752,
          "originalHeight": 3835,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vm3q88lXyKIgUv_nLOasEA--~B/aD0zODM1O3c9NTc1MjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-02/ca865c10-03ab-11f1-b9f7-54bd7d25ed54.cf.webp",
              "width": 5752,
              "height": 3835,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wMd6QYLC2_o9YWVkSyTWDg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-02/ca865c10-03ab-11f1-b9f7-54bd7d25ed54.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hims--hers-stock-crashes-after-fda-announces-plans-to-take-decisive-steps-against-glp-1-compounds-154907212.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hims--hers-stock-crashes-after-fda-announces-plans-to-take-decisive-steps-against-glp-1-compounds-154907212.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T15:43:39+00:00",
    "headline": "Eli Lilly to Acquire Orna Therapeutics in $2.4 Billion Deal",
    "summary": "Eli Lilly (LLY) agreed to acquire Orna Therapeutics, a biotechnology company focused on engineering",
    "url": "https://finance.yahoo.com/news/eli-lilly-acquire-orna-therapeutics-154339593.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "f34d4843-8298-3bec-b8e6-63c43bed7a1f",
      "content": {
        "id": "f34d4843-8298-3bec-b8e6-63c43bed7a1f",
        "contentType": "STORY",
        "title": "Eli Lilly to Acquire Orna Therapeutics in $2.4 Billion Deal",
        "description": "",
        "summary": "Eli Lilly (LLY) agreed to acquire Orna Therapeutics, a biotechnology company focused on engineering",
        "pubDate": "2026-02-09T15:43:39Z",
        "displayTime": "2026-02-09T15:43:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/6fcb0e4daa23894ba9c15e5da184e3ec",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "elililly - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YdChze6TwjaAcf9wQBVtXw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/6fcb0e4daa23894ba9c15e5da184e3ec.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Lxi7q1ztTvSWKCYpfuiGyA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/6fcb0e4daa23894ba9c15e5da184e3ec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-acquire-orna-therapeutics-154339593.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-acquire-orna-therapeutics-154339593.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T15:23:12+00:00",
    "headline": "Novo Nordisk sues Hims after $49 weight-loss pill sparks FDA backlash",
    "summary": "COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk sued Hims and Hers Health on Monday over patent infringement after the U. telehealth firm launched, then cancelled, a $49 copy of Novo's weight-loss pill Wegovy following a swift backlash from U.",
    "url": "https://uk.finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "eba1a6c5-1069-3b02-9249-bb65961b531a",
      "content": {
        "id": "eba1a6c5-1069-3b02-9249-bb65961b531a",
        "contentType": "STORY",
        "title": "Novo Nordisk sues Hims after $49 weight-loss pill sparks FDA backlash",
        "description": "",
        "summary": "COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk sued Hims and Hers Health on Monday over patent infringement after the U. telehealth firm launched, then cancelled, a $49 copy of Novo's weight-loss pill Wegovy following a swift backlash from U.",
        "pubDate": "2026-02-09T15:23:12Z",
        "displayTime": "2026-02-09T15:23:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/6442b2cd483ff58c06265f8cc7742d06",
          "originalWidth": 800,
          "originalHeight": 527,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PZBBnZmdOYlNatk_bCEitg--~B/aD01Mjc7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/6442b2cd483ff58c06265f8cc7742d06.cf.webp",
              "width": 800,
              "height": 527,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s_iv1jzQesLYqedbwA6AAA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/6442b2cd483ff58c06265f8cc7742d06.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://uk.finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
          "site": "finance",
          "region": "GB",
          "lang": "en-GB"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-shares-rise-hims-074530459.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T15:22:40+00:00",
    "headline": "Hims & Hers Plummets On FDA Crackdown, Novo Nordisk Lawsuit",
    "summary": "Hims stock crashed Monday after Novo Nordisk filed a lawsuit, claiming the online pharmacy is \"deceiving patients\" with its compounded drugs.",
    "url": "https://www.investors.com/news/technology/hims-stock-novo-nordisk-lawsuit-compounded-semaglutide/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "ad53b6bc-c497-3ba5-bd45-b3605774654d",
      "content": {
        "id": "ad53b6bc-c497-3ba5-bd45-b3605774654d",
        "contentType": "STORY",
        "title": "Hims & Hers Plummets On FDA Crackdown, Novo Nordisk Lawsuit",
        "description": "",
        "summary": "Hims stock crashed Monday after Novo Nordisk filed a lawsuit, claiming the online pharmacy is \"deceiving patients\" with its compounded drugs.",
        "pubDate": "2026-02-09T15:22:40Z",
        "displayTime": "2026-02-09T15:22:40Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/ad53b6bc-c497-3ba5-bd45-b3605774654d/hims-hers-plummets-on-fda.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/350362ec82f02d5b069b5564fa0175f0",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UIG5.V7xKrNq4RCVtcJ0UQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/350362ec82f02d5b069b5564fa0175f0.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/h32blwXqrUPfFUDxCSzK7g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/350362ec82f02d5b069b5564fa0175f0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/hims-stock-novo-nordisk-lawsuit-compounded-semaglutide/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "HIMS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T14:56:00+00:00",
    "headline": "Hims & Hers Stock Plunges 25%. Its Weight Loss Drug Strategy Backfired.",
    "summary": "Heightened regulatory scrutiny could be a major blow for the online drug retailer, which just shelved its plan for a Wegovy copycat.",
    "url": "https://www.barrons.com/articles/hims-hers-stock-price-wight-loss-drug-novo-nordisk-llilly-wegovy-9b7e26db?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "3bdf7c21-9b76-30b5-9407-e5570705df84",
      "content": {
        "id": "3bdf7c21-9b76-30b5-9407-e5570705df84",
        "contentType": "STORY",
        "title": "Hims & Hers Stock Plunges 25%. Its Weight Loss Drug Strategy Backfired.",
        "description": "",
        "summary": "Heightened regulatory scrutiny could be a major blow for the online drug retailer, which just shelved its plan for a Wegovy copycat.",
        "pubDate": "2026-02-09T14:56:00Z",
        "displayTime": "2026-02-09T14:56:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/3bdf7c21-9b76-30b5-9407-e5570705df84/hims-hers-stock-plunges.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/3985777ea4a8bee88d7fbde151eccb25",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/26KOn6oaSzam4fyehZ4clw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/3985777ea4a8bee88d7fbde151eccb25.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/phkijlebsiYXfKV4N8Qtzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/3985777ea4a8bee88d7fbde151eccb25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/hims-hers-stock-price-wight-loss-drug-novo-nordisk-llilly-wegovy-9b7e26db?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T14:11:00+00:00",
    "headline": "Should You Buy, Sell or Hold Pfizer Stock After a Lukewarm Q4?",
    "summary": "PFE beat Q4 estimates, but weak COVID sales and soft 2026 guidance kept shares muted as investors weigh pipeline strength against looming headwinds.",
    "url": "https://finance.yahoo.com/news/buy-sell-hold-pfizer-stock-141100002.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2a6f9360-cb81-34af-96b1-49859761060c",
      "content": {
        "id": "2a6f9360-cb81-34af-96b1-49859761060c",
        "contentType": "STORY",
        "title": "Should You Buy, Sell or Hold Pfizer Stock After a Lukewarm Q4?",
        "description": "",
        "summary": "PFE beat Q4 estimates, but weak COVID sales and soft 2026 guidance kept shares muted as investors weigh pipeline strength against looming headwinds.",
        "pubDate": "2026-02-09T14:11:00Z",
        "displayTime": "2026-02-09T14:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YqcOBKMNrThKvJSga1KIbw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Vj9Bix098SQE5mY9G0P2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/buy-sell-hold-pfizer-stock-141100002.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-sell-hold-pfizer-stock-141100002.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T14:00:06+00:00",
    "headline": "Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finance.yahoo.com/news/eli-lilly-company-lly-attracting-140006122.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "3007f6e5-256b-3a8e-95ab-d62e1b89ab04",
      "content": {
        "id": "3007f6e5-256b-3a8e-95ab-d62e1b89ab04",
        "contentType": "STORY",
        "title": "Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know",
        "description": "",
        "summary": "Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
        "pubDate": "2026-02-09T14:00:06Z",
        "displayTime": "2026-02-09T14:00:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43",
          "originalWidth": 900,
          "originalHeight": 601,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/E8QyPjKtRaOQj91uVCJHQA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43.cf.webp",
              "width": 900,
              "height": 601,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hjTg63kWHBfUb8JQmmr1kg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-company-lly-attracting-140006122.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-company-lly-attracting-140006122.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T19:50:00+00:00",
    "headline": "Novo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment?",
    "summary": "These stocks have been going in opposite directions of late, but that doesn't mean that trend will continue.",
    "url": "https://www.fool.com/investing/2026/02/09/novo-nordisk-vs-eli-lilly-whats-the-better-long-te/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "88b9a865-5247-37a0-9792-92b7f278e4b5",
      "content": {
        "id": "88b9a865-5247-37a0-9792-92b7f278e4b5",
        "contentType": "STORY",
        "title": "Novo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment?",
        "description": "",
        "summary": "These stocks have been going in opposite directions of late, but that doesn't mean that trend will continue.",
        "pubDate": "2026-02-09T19:50:00Z",
        "displayTime": "2026-02-09T19:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/1fd84c2a60b00a6ca904dea095fe4567",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "Weight-loss pills with measuring tape.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2w1b.IfSLHQ_8gNJjRxkJw--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/1fd84c2a60b00a6ca904dea095fe4567.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cZDMrLeLA9fIDxAgcTrXGA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/1fd84c2a60b00a6ca904dea095fe4567.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/09/novo-nordisk-vs-eli-lilly-whats-the-better-long-te/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-vs-eli-lilly-195000887.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "INTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T19:19:00+00:00",
    "headline": "Novo Nordisk Escalates Fight Against Hims & Hers",
    "summary": "The Danish drugmaker’s patent lawsuit is the company’s latest effort to shore up its place in the booming weight-loss drug market.",
    "url": "https://www.wsj.com/health/pharma/novo-nordisk-escalates-fight-against-hims-hers-69c15e2b?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "328b1fdc-ef81-3ac1-bcbf-f63fbf804bf4",
      "content": {
        "id": "328b1fdc-ef81-3ac1-bcbf-f63fbf804bf4",
        "contentType": "STORY",
        "title": "Novo Nordisk Escalates Fight Against Hims & Hers",
        "description": "",
        "summary": "The Danish drugmaker’s patent lawsuit is the company’s latest effort to shore up its place in the booming weight-loss drug market.",
        "pubDate": "2026-02-09T19:19:00Z",
        "displayTime": "2026-02-09T19:19:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/328b1fdc-ef81-3ac1-bcbf-f63fbf804bf4/novo-nordisk-escalates-fight.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/c9415149766e29ce42427e1d2115b693",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w8nTZQ3kpCT45bB9LCPK1w--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/c9415149766e29ce42427e1d2115b693.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/W9CDX9Ho7ds8hjsKA7ES9g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/c9415149766e29ce42427e1d2115b693.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/novo-nordisk-escalates-fight-against-hims-hers-69c15e2b?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T18:50:41+00:00",
    "headline": "Sector Update: Health Care Stocks Decline Monday Afternoon",
    "summary": "Health care stocks were lower Monday afternoon, with the NYSE Health Care Index shedding 0.9% and th",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-185041546.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "b6a4419b-62d4-3e22-b12c-d7c9550d47e0",
      "content": {
        "id": "b6a4419b-62d4-3e22-b12c-d7c9550d47e0",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Decline Monday Afternoon",
        "description": "",
        "summary": "Health care stocks were lower Monday afternoon, with the NYSE Health Care Index shedding 0.9% and th",
        "pubDate": "2026-02-09T18:50:41Z",
        "displayTime": "2026-02-09T18:50:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-185041546.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-185041546.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "HUMA"
            },
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "BDX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T18:00:11+00:00",
    "headline": "Eli Lilly bets on in vivo cell therapy in $2.4bn Orna Therapeutics buyout",
    "summary": "Lilly joins the growing list of big pharma companies hoping to see success from their acquired in vivo CAR-T programmes.",
    "url": "https://www.pharmaceutical-technology.com/news/eli-lilly-acquires-orna-therapeutics-in-vivo-car-t-2-4bn/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "590bc6fc-2b28-34c1-a0cc-56e13be58997",
      "content": {
        "id": "590bc6fc-2b28-34c1-a0cc-56e13be58997",
        "contentType": "STORY",
        "title": "Eli Lilly bets on in vivo cell therapy in $2.4bn Orna Therapeutics buyout",
        "description": "",
        "summary": "Lilly joins the growing list of big pharma companies hoping to see success from their acquired in vivo CAR-T programmes.",
        "pubDate": "2026-02-09T18:00:11Z",
        "displayTime": "2026-02-09T18:00:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/9e2936388124fff92c4da39356eec91c",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Lilly's Orna acquisition will see the company throw its hat into the in vivo cell therapy ring",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vXvwMwwKAQc3YM2oicIdMQ--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/9e2936388124fff92c4da39356eec91c.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_A1fYzLvXY8b8DVFk2j3Nw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/9e2936388124fff92c4da39356eec91c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/eli-lilly-acquires-orna-therapeutics-in-vivo-car-t-2-4bn/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-bets-vivo-cell-180011724.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T16:50:00+00:00",
    "headline": "Over 60% of Eli Lilly's Revenue Comes From Its GLP-1 Drugs. Should Investors Be Worried?",
    "summary": "Mounjaro and Zepbound generated a combined $11.7 billion in sales for the company in its most recent quarter.",
    "url": "https://www.fool.com/investing/2026/02/09/over-60-of-eli-lillys-revenue-comes-from-its-glp-1/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "30c64304-5151-36d6-970c-b46be1124f4e",
      "content": {
        "id": "30c64304-5151-36d6-970c-b46be1124f4e",
        "contentType": "STORY",
        "title": "Over 60% of Eli Lilly's Revenue Comes From Its GLP-1 Drugs. Should Investors Be Worried?",
        "description": "",
        "summary": "Mounjaro and Zepbound generated a combined $11.7 billion in sales for the company in its most recent quarter.",
        "pubDate": "2026-02-09T16:50:00Z",
        "displayTime": "2026-02-09T16:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/0727425e63628f97f027b6abe7f732fe",
          "originalWidth": 1100,
          "originalHeight": 733,
          "caption": "Person measuring their waist.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3INhIo4oRjvnnFQWG.hePQ--~B/aD03MzM7dz0xMTAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/0727425e63628f97f027b6abe7f732fe.cf.webp",
              "width": 1100,
              "height": 733,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JDm6TsOwRmVE_tgBQJ6K6A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/0727425e63628f97f027b6abe7f732fe.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/09/over-60-of-eli-lillys-revenue-comes-from-its-glp-1/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/over-60-eli-lillys-revenue-165000145.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T16:38:00+00:00",
    "headline": "Will These 5 Drug Bigwigs Surpass Q4 Earnings Forecasts?",
    "summary": "Let's look at five pharma and biotech companies, AZN, INCY, GILD, VRTX and MRNA, which are scheduled to release their fourth-quarter 2025 results this week.",
    "url": "https://finance.yahoo.com/news/5-drug-bigwigs-surpass-q4-163800508.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "aec30b43-0d70-317c-b6bb-2d4b849ada6c",
      "content": {
        "id": "aec30b43-0d70-317c-b6bb-2d4b849ada6c",
        "contentType": "STORY",
        "title": "Will These 5 Drug Bigwigs Surpass Q4 Earnings Forecasts?",
        "description": "",
        "summary": "Let's look at five pharma and biotech companies, AZN, INCY, GILD, VRTX and MRNA, which are scheduled to release their fourth-quarter 2025 results this week.",
        "pubDate": "2026-02-09T16:38:00Z",
        "displayTime": "2026-02-09T16:38:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890",
          "originalWidth": 620,
          "originalHeight": 393,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/owRrQw..RZz13mqQwVBgRA--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890.cf.webp",
              "width": 620,
              "height": 393,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xvPk7PEgDBlSHxNlV1Nayw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-drug-bigwigs-surpass-q4-163800508.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-drug-bigwigs-surpass-q4-163800508.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SNY"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T16:36:42+00:00",
    "headline": "Top Midday Stories: Novo Nordisk Sues Hims for Alleged Patent Infringement; Transocean to Acquire Valaris for $5.8 Billion",
    "summary": "All three major US stock indexes were up in late-morning trading Monday, as investors look ahead to",
    "url": "https://finance.yahoo.com/news/top-midday-stories-novo-nordisk-163642172.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "72551f98-11de-3ba5-8003-2e6c2563fd8a",
      "content": {
        "id": "72551f98-11de-3ba5-8003-2e6c2563fd8a",
        "contentType": "STORY",
        "title": "Top Midday Stories: Novo Nordisk Sues Hims for Alleged Patent Infringement; Transocean to Acquire Valaris for $5.8 Billion",
        "description": "",
        "summary": "All three major US stock indexes were up in late-morning trading Monday, as investors look ahead to",
        "pubDate": "2026-02-09T16:36:42Z",
        "displayTime": "2026-02-09T16:36:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-novo-nordisk-163642172.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-novo-nordisk-163642172.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "RIG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T16:25:46+00:00",
    "headline": "Novo sues Hims & Hers despite Wegovy pill offering U-turn",
    "summary": "Novo and Hims & Hers have continually locked horns over the legality of obesity drug offerings.",
    "url": "https://www.pharmaceutical-technology.com/news/novo-sues-hims-hers-despite-wegovy-pill-offering-u-turn/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "3fe85cff-59e5-3109-b693-6ea87224e459",
      "content": {
        "id": "3fe85cff-59e5-3109-b693-6ea87224e459",
        "contentType": "STORY",
        "title": "Novo sues Hims & Hers despite Wegovy pill offering U-turn",
        "description": "",
        "summary": "Novo and Hims & Hers have continually locked horns over the legality of obesity drug offerings.",
        "pubDate": "2026-02-09T16:25:46Z",
        "displayTime": "2026-02-09T16:25:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/9965dcb7574c1e58582dbd442cafe16c",
          "originalWidth": 1000,
          "originalHeight": 627,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ea_h4_rU.1EYJJTJ8UeaRw--~B/aD02Mjc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/9965dcb7574c1e58582dbd442cafe16c.cf.webp",
              "width": 1000,
              "height": 627,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fzLu.Rrwy4JcJV6chYrGNg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/9965dcb7574c1e58582dbd442cafe16c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/novo-sues-hims-hers-despite-wegovy-pill-offering-u-turn/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-sues-hims-hers-despite-162546091.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T16:25:00+00:00",
    "headline": "Hims & Hers Stock Plunges 24%. Its Weight-Loss Drug Strategy Backfired.",
    "summary": "Heightened regulatory scrutiny could be a major blow for the online drug retailer, which just shelved its plan for a Wegovy copycat.",
    "url": "https://www.barrons.com/articles/hims-hers-stock-price-wight-loss-drug-novo-nordisk-llilly-wegovy-9b7e26db?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "3bdf7c21-9b76-30b5-9407-e5570705df84",
      "content": {
        "id": "3bdf7c21-9b76-30b5-9407-e5570705df84",
        "contentType": "STORY",
        "title": "Hims & Hers Stock Plunges 24%. Its Weight-Loss Drug Strategy Backfired.",
        "description": "",
        "summary": "Heightened regulatory scrutiny could be a major blow for the online drug retailer, which just shelved its plan for a Wegovy copycat.",
        "pubDate": "2026-02-09T16:25:00Z",
        "displayTime": "2026-02-09T16:25:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/3bdf7c21-9b76-30b5-9407-e5570705df84/hims-hers-stock-plunges.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/3985777ea4a8bee88d7fbde151eccb25",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/26KOn6oaSzam4fyehZ4clw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/3985777ea4a8bee88d7fbde151eccb25.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/phkijlebsiYXfKV4N8Qtzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/3985777ea4a8bee88d7fbde151eccb25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/hims-hers-stock-price-wight-loss-drug-novo-nordisk-llilly-wegovy-9b7e26db?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "WW"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T16:05:58+00:00",
    "headline": "Why Eli Lilly Stock Just Popped",
    "summary": "Novo Nordisk just did Eli Lilly stock a huge favor.",
    "url": "https://www.fool.com/investing/2026/02/09/why-eli-lilly-stock-just-popped/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "22f4e33c-4d2a-3005-ba2f-94cd317201ae",
      "content": {
        "id": "22f4e33c-4d2a-3005-ba2f-94cd317201ae",
        "contentType": "STORY",
        "title": "Why Eli Lilly Stock Just Popped",
        "description": "",
        "summary": "Novo Nordisk just did Eli Lilly stock a huge favor.",
        "pubDate": "2026-02-09T16:05:58Z",
        "displayTime": "2026-02-09T16:05:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/a121dc527e75a32b79f45db56c1a022f",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "Woman injecting self in arm with a GLP-1 injector pen.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VAr_kXFw4r0S8QNDsVHnMg--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/a121dc527e75a32b79f45db56c1a022f.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cWX_YQJLsawuOu8HovrWmQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/a121dc527e75a32b79f45db56c1a022f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/09/why-eli-lilly-stock-just-popped/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-eli-lilly-stock-just-160558633.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "INTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T16:05:00+00:00",
    "headline": "Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion",
    "summary": "Eli Lilly  shares rose Monday after the Mounjaro maker said it had agreed to acquire biotechnology company Orna Therapeutics for $2.4 billion in cash.  The deal value comprises an upfront payment and subsequent payments upon the achievement of clinical development milestones, Lilly said on Monday.  Orna Therapeutics develops RNA drugs targeting cancers, genetic disorders, and other chronic conditions.",
    "url": "https://www.barrons.com/articles/eli-lilly-stock-orna-acquisition-f7249955?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "de7539fd-667e-396a-9d25-63c19eb882e5",
      "content": {
        "id": "de7539fd-667e-396a-9d25-63c19eb882e5",
        "contentType": "STORY",
        "title": "Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion",
        "description": "",
        "summary": "Eli Lilly  shares rose Monday after the Mounjaro maker said it had agreed to acquire biotechnology company Orna Therapeutics for $2.4 billion in cash.  The deal value comprises an upfront payment and subsequent payments upon the achievement of clinical development milestones, Lilly said on Monday.  Orna Therapeutics develops RNA drugs targeting cancers, genetic disorders, and other chronic conditions.",
        "pubDate": "2026-02-09T16:05:00Z",
        "displayTime": "2026-02-09T16:05:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/de7539fd-667e-396a-9d25-63c19eb882e5/eli-lilly-to-buy-cell-therapy.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/441bbf15e12a2f0ee553d116e82ffd12",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3oke2VoyBuVXihS7iPanPA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/441bbf15e12a2f0ee553d116e82ffd12.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jF0dFF4yYnylMoHzf4gbhA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/441bbf15e12a2f0ee553d116e82ffd12.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/eli-lilly-stock-orna-acquisition-f7249955?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "IVBIY"
            },
            {
              "symbol": "IVBXF"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T14:55:00+00:00",
    "headline": "Novo Nordisk Stock Whipsawed by GLP-1 Pill Fears: Relief Ahead?",
    "summary": "NVO shares swing sharply after fears over cheap compounded GLP-1 pills, before FDA action and a Hims retreat spark a sharp rebound.",
    "url": "https://finance.yahoo.com/news/novo-nordisk-stock-whipsawed-glp-145500326.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "4bf72f3f-df13-3114-9c10-77a3f56acc72",
      "content": {
        "id": "4bf72f3f-df13-3114-9c10-77a3f56acc72",
        "contentType": "STORY",
        "title": "Novo Nordisk Stock Whipsawed by GLP-1 Pill Fears: Relief Ahead?",
        "description": "",
        "summary": "NVO shares swing sharply after fears over cheap compounded GLP-1 pills, before FDA action and a Hims retreat spark a sharp rebound.",
        "pubDate": "2026-02-09T14:55:00Z",
        "displayTime": "2026-02-09T14:55:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/08c70fc44d9b8340859581d38311e071",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JLDGQt80ARh3qkafoo9TaA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08c70fc44d9b8340859581d38311e071.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ncdWYZW_rP_HUKWXjdodfA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08c70fc44d9b8340859581d38311e071.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-stock-whipsawed-glp-145500326.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-stock-whipsawed-glp-145500326.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T14:15:06+00:00",
    "headline": "Unlocking Lilly (LLY) International Revenues: Trends, Surprises, and Prospects",
    "summary": "Explore how Lilly's (LLY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.",
    "url": "https://finance.yahoo.com/news/unlocking-lilly-lly-international-revenues-141506360.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "49abc28b-354f-35cb-9e01-a32382d36a88",
      "content": {
        "id": "49abc28b-354f-35cb-9e01-a32382d36a88",
        "contentType": "STORY",
        "title": "Unlocking Lilly (LLY) International Revenues: Trends, Surprises, and Prospects",
        "description": "",
        "summary": "Explore how Lilly's (LLY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.",
        "pubDate": "2026-02-09T14:15:06Z",
        "displayTime": "2026-02-09T14:15:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9",
          "originalWidth": 900,
          "originalHeight": 845,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EqK8ApWUE5x_2yrT2tcofA--~B/aD04NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9.cf.webp",
              "width": 900,
              "height": 845,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/echl9KTe6EOuSV3hwRYFlw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/unlocking-lilly-lly-international-revenues-141506360.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/unlocking-lilly-lly-international-revenues-141506360.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T12:10:00+00:00",
    "headline": "Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals",
    "summary": "Worth up to $2.4 billion, the acquisition is also the latest in a series of buyouts involving startups with technologies that modify immune cells inside the body.",
    "url": "https://www.biopharmadive.com/news/lilly-orna-acquire-in-vivo-cell-therapy-autoimmune/811692/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "2122e62a-455e-38fc-8f65-af5e898ff459",
      "content": {
        "id": "2122e62a-455e-38fc-8f65-af5e898ff459",
        "contentType": "STORY",
        "title": "Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals",
        "description": "",
        "summary": "Worth up to $2.4 billion, the acquisition is also the latest in a series of buyouts involving startups with technologies that modify immune cells inside the body.",
        "pubDate": "2026-02-09T12:10:00Z",
        "displayTime": "2026-02-09T12:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/997792bec5aff4b1ccb5fb946a51251c",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/54zQZD3mlLZVCx2Apva4Bg--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/997792bec5aff4b1ccb5fb946a51251c.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A2HKyX8zdXTMCUVw29USFQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/997792bec5aff4b1ccb5fb946a51251c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/lilly-orna-acquire-in-vivo-cell-therapy-autoimmune/811692/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-buys-vivo-car-t-121000782.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T11:00:00+00:00",
    "headline": "Lilly bets again on China drugs; Roche showcases MS data",
    "summary": "Lilly could pay Innovent Biologics up to $9 billion in a new alliance. Elsewhere, Roche tried to assuage investor concerns about its new multiple sclerosis drug and Roivant shares surged.",
    "url": "https://www.biopharmadive.com/news/lilly-bets-again-on-china-drugs-roche-showcases-ms-data/811669/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "bd6b95a1-783e-3009-b928-272d94bc890c",
      "content": {
        "id": "bd6b95a1-783e-3009-b928-272d94bc890c",
        "contentType": "STORY",
        "title": "Lilly bets again on China drugs; Roche showcases MS data",
        "description": "",
        "summary": "Lilly could pay Innovent Biologics up to $9 billion in a new alliance. Elsewhere, Roche tried to assuage investor concerns about its new multiple sclerosis drug and Roivant shares surged.",
        "pubDate": "2026-02-09T11:00:00Z",
        "displayTime": "2026-02-09T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YSECyFvzK8sIEiUW4LIicA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/heEgXBvKL8Y58FXAXGaXPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/lilly-bets-again-on-china-drugs-roche-showcases-ms-data/811669/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-bets-again-china-drugs-110000910.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IVBIY"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T21:28:00+00:00",
    "headline": "Hims & Hers Stock Plunges 16%. Its Weight-Loss Drug Strategy Backfired.",
    "summary": "Heightened regulatory scrutiny could be a major blow for the online drug retailer, which just shelved its plan for a Wegovy copycat.",
    "url": "https://www.barrons.com/articles/hims-hers-stock-price-wight-loss-drug-novo-nordisk-llilly-wegovy-9b7e26db?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "3bdf7c21-9b76-30b5-9407-e5570705df84",
      "content": {
        "id": "3bdf7c21-9b76-30b5-9407-e5570705df84",
        "contentType": "STORY",
        "title": "Hims & Hers Stock Plunges 16%. Its Weight-Loss Drug Strategy Backfired.",
        "description": "",
        "summary": "Heightened regulatory scrutiny could be a major blow for the online drug retailer, which just shelved its plan for a Wegovy copycat.",
        "pubDate": "2026-02-09T21:28:00Z",
        "displayTime": "2026-02-09T21:28:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/3bdf7c21-9b76-30b5-9407-e5570705df84/hims-hers-stock-plunges.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/3985777ea4a8bee88d7fbde151eccb25",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/26KOn6oaSzam4fyehZ4clw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/3985777ea4a8bee88d7fbde151eccb25.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/phkijlebsiYXfKV4N8Qtzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/3985777ea4a8bee88d7fbde151eccb25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/hims-hers-stock-price-wight-loss-drug-novo-nordisk-llilly-wegovy-9b7e26db?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "WW"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T21:00:24+00:00",
    "headline": "Sector Update: Health Care Stocks Fall Late Afternoon",
    "summary": "Health care stocks were lower late Monday afternoon, with the NYSE Health Care Index shedding 0.6% a",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-fall-210024364.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "441b94ee-0d9e-3601-a451-1f74f138198e",
      "content": {
        "id": "441b94ee-0d9e-3601-a451-1f74f138198e",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Fall Late Afternoon",
        "description": "",
        "summary": "Health care stocks were lower late Monday afternoon, with the NYSE Health Care Index shedding 0.6% a",
        "pubDate": "2026-02-09T21:00:24Z",
        "displayTime": "2026-02-09T21:00:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-fall-210024364.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-fall-210024364.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T14:30:00+00:00",
    "headline": "Market Minute 2-9-26- Markets Meander After Dow Hits 50K",
    "summary": "Stock markets are meandering following Friday’s strong rally. Meanwhile, gold and silver are rising, the dollar is sliding, and crude oil is flat.",
    "url": "https://finance.yahoo.com/news/market-minute-2-9-26-143000376.html",
    "source": "MoneyShow",
    "provider": "yfinance",
    "raw": {
      "id": "f7006c75-2476-3a7b-b2fe-8d6c209e74e5",
      "content": {
        "id": "f7006c75-2476-3a7b-b2fe-8d6c209e74e5",
        "contentType": "STORY",
        "title": "Market Minute 2-9-26- Markets Meander After Dow Hits 50K",
        "description": "",
        "summary": "Stock markets are meandering following Friday’s strong rally. Meanwhile, gold and silver are rising, the dollar is sliding, and crude oil is flat.",
        "pubDate": "2026-02-09T14:30:00Z",
        "displayTime": "2026-02-09T14:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/moneyshow_610/bdfd9df03a9e815628b6851c45919f97",
          "originalWidth": 561,
          "originalHeight": 312,
          "caption": "chart",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4Les.DI4MrE1EGEXf1LE2g--~B/aD0zMTI7dz01NjE7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneyshow_610/bdfd9df03a9e815628b6851c45919f97.cf.webp",
              "width": 561,
              "height": 312,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yMN9D47daga9eXSBln9k0g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneyshow_610/bdfd9df03a9e815628b6851c45919f97.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MoneyShow",
          "url": "https://www.moneyshow.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/market-minute-2-9-26-143000376.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/market-minute-2-9-26-143000376.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "GC=F"
            },
            {
              "symbol": "DX-Y.NYB"
            },
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "SI=F"
            },
            {
              "symbol": "^DJT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]